Boston Scientific · 12 hours ago
Program Manager, AI Partnerships and Enablement
Boston Scientific is a leader in medical science, committed to solving significant health industry challenges. In this role, you will lead and accelerate MedTech AI initiatives, managing partnerships and driving AI transformation across the organization.
Health CareMedicalMedical Device
Responsibilities
Lead enterprise AI transformation programs by owning strategy, multi-year roadmaps, governance, and execution for large, cross-functional AI initiatives spanning multiple functions and workstreams
Drive measurable value realization by defining value cases and KPIs (for example, cycle time reduction, quality improvements, productivity gains, cost avoidance, innovation throughput) and establishing mechanisms to track outcomes from delivery through sustained adoption
Establish program operating cadence and governance by supporting executive steering forums, portfolio prioritization, decision logs, and risk and issue management, ensuring clear accountability across R&D, Clinical, Quality, Regulatory, IT, Data and AI, Privacy, and Cybersecurity
Drive AI change enablement at scale by designing and executing adoption strategies across R&D, clinical, and business workflows, including stakeholder mapping, communications, training, champion networks, feedback loops, and reinforcement plans
Support AI capabilities and organizational literacy by leading teams that develop and deliver capability-building programs tailored to key personas such as engineers, scientists, clinicians, and program leaders
Enable process improvement with AI by identifying, prioritizing, and operationalizing AI-enabled enhancements to internal processes, including R&D documentation, risk management, verification and validation planning, clinical evidence development, knowledge management, and post-market feedback loops
Define scalable delivery playbooks and operating models by creating reusable intake, feasibility, validation, deployment readiness, and monitoring frameworks to ensure consistent AI solution delivery
Lead and govern strategic partnerships by developing and managing relationships with AI vendors, consultants, health systems, and healthcare organizations, defining joint roadmaps, success metrics, and governance structures
Serve as a senior stakeholder influencer by acting as a primary point of contact across technical, clinical, and business leaders, aligning executives on objectives, tradeoffs, and investment decisions
Ensure risk-aware delivery in regulated environments by embedding regulatory, patient safety, privacy, cybersecurity, and Responsible AI considerations into program execution and partnering with Quality and Regulatory teams to ensure audit-ready documentation and governance
Qualification
Required
Bachelor's degree in engineering, computer science, business, healthcare, or a related field
Minimum of 7 years' experience in program or project management
Minimum of 3 years' experience leading AI, MedTech, healthcare, or data-driven initiatives
Demonstrated ability to lead complex, multi-stakeholder programs from concept through adoption, including work with external technology partners
Strong program execution discipline, including planning, risk management, dependency management, and outcomes tracking
Excellent communication and influence skills with the ability to engage stakeholders at all organizational levels
Working knowledge of regulatory and compliance considerations within MedTech and healthcare AI environments
Preferred
Advanced degree such as an MBA, MS, or PhD
Demonstrated change-management leadership driving adoption of digital or AI capabilities across clinical and business workflows
Proven success building trusted partnerships and operating effectively within highly matrixed organizations
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
2026-02-04
2026-02-03
Company data provided by crunchbase